Equillium, Inc.

NasdaqCM:EQ Stock Report

Market Cap: US$26.2m

Equillium Management

Management criteria checks 3/4

Equillium's CEO is Bruce Steel, appointed in Jan 2006, has a tenure of 18.83 years. total yearly compensation is $1.35M, comprised of 33.8% salary and 66.2% bonuses, including company stock and options. directly owns 10.48% of the company’s shares, worth $2.75M. The average tenure of the management team and the board of directors is 6.7 years and 6.2 years respectively.

Key information

Bruce Steel

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage33.8%
CEO tenure18.8yrs
CEO ownership10.5%
Management average tenure6.7yrs
Board average tenure6.2yrs

Recent management updates

Recent updates

Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge

Nov 16
Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge

Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop

Sep 26
Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop

Benign Growth For Equillium, Inc. (NASDAQ:EQ) Underpins Stock's 54% Plummet

Jun 16
Benign Growth For Equillium, Inc. (NASDAQ:EQ) Underpins Stock's 54% Plummet

We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully

May 01
We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully

Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues

Mar 27
Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues

Analyst Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Aug 14
Analyst Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Earnings Release: Here's Why Analysts Cut Their Equillium, Inc. (NASDAQ:EQ) Price Target To US$6.06

Aug 12
Earnings Release: Here's Why Analysts Cut Their Equillium, Inc. (NASDAQ:EQ) Price Target To US$6.06

Broker Revenue Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

May 03
Broker Revenue Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Does Equillium (NASDAQ:EQ) Have A Healthy Balance Sheet?

Mar 26
Does Equillium (NASDAQ:EQ) Have A Healthy Balance Sheet?

Equillium GAAP EPS of -$0.41 in-line

Aug 15

Equillium CEO Bruce Steel - Drugs For Autoimmune, Inflammatory Disorders (Video)

Oct 08

Is Equillium, Inc.'s (NASDAQ:EQ) Shareholder Ownership Skewed Towards Insiders?

Mar 09
Is Equillium, Inc.'s (NASDAQ:EQ) Shareholder Ownership Skewed Towards Insiders?

Equillium prices $30M registered direct offering

Feb 04

Equillium (EQ) Investor Presentation - Slideshow

Dec 04

How Much Of Equillium, Inc. (NASDAQ:EQ) Do Insiders Own?

Nov 24
How Much Of Equillium, Inc. (NASDAQ:EQ) Do Insiders Own?

FDA gives green signal to Equillium's late-stage COVID-19 trial

Oct 30

CEO Compensation Analysis

How has Bruce Steel's remuneration changed compared to Equillium's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$12m

Dec 31 2023US$1mUS$455k

-US$13m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$2mUS$455k

-US$62m

Sep 30 2022n/an/a

-US$76m

Jun 30 2022n/an/a

-US$72m

Mar 31 2022n/an/a

-US$67m

Dec 31 2021US$2mUS$440k

-US$39m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$31m

Dec 31 2020US$782kUS$198k

-US$30m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$27m

Dec 31 2019US$1mUS$396k

-US$26m

Sep 30 2019n/an/a

-US$23m

Jun 30 2019n/an/a

-US$22m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018US$452kUS$219k

-US$13m

Compensation vs Market: Bruce's total compensation ($USD1.35M) is above average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Bruce's compensation has been consistent with company performance over the past year.

CEO

Bruce Steel (58 yo)

18.8yrs

Tenure

US$1,348,215

Compensation

Mr. Bruce D. Steel, CFA has been Chief Executive Officer of Equillium, Inc. since January 1, 2020. He has been a Managing Director at BioMed Ventures LP since September 2010. Mr. Steel serves as President...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Bradbury
Executive Chairman7.7yrsUS$267.30k5.29%
$ 1.4m
Bruce Steel
Co-Founder18.8yrsUS$1.35m10.48%
$ 2.7m
Christine Zedelmayer
Senior VP & COO6.8yrsUS$785.51k0.38%
$ 100.1k
Stephen Connelly
Chief Scientific Officer & Director6.8yrsUS$827.25k2.8%
$ 734.8k
Jason Keyes
Chief Financial Officer6.7yrsno data0.34%
$ 90.0k
Penny Tom
Senior VP of Finance & Principal Accounting Officerno datano data0.018%
$ 4.8k
Michael Moore
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Matthew Ritter
Senior Vice President of Corporate Development4.5yrsno datano data
Joel Rothman
Chief Development Officer4.9yrsno data0.16%
$ 43.0k

6.7yrs

Average Tenure

54.5yo

Average Age

Experienced Management: EQ's management team is seasoned and experienced (6.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Daniel Bradbury
Executive Chairman7.7yrsUS$267.30k5.29%
$ 1.4m
Bruce Steel
Co-Founder7.7yrsUS$1.35m10.48%
$ 2.7m
Stephen Connelly
Chief Scientific Officer & Director7.7yrsUS$827.25k2.8%
$ 734.8k
Martha Demski
Independent Director6.2yrsUS$98.77k0.067%
$ 17.6k
Bala Manian
Independent Director7.5yrsUS$101.79k0.067%
$ 17.6k
Thomas Daniel
Member of Scientific & Clinical Advisory Board5.5yrsno datano data
Mark Pruzanski
Independent Director6.2yrsUS$83.77k0.067%
$ 17.6k
Vijay Kuchroo
Member of Scientific & Clinical Advisory Boardno datano datano data
Barbara Troupin
Independent Director2.8yrsUS$65.25k0%
$ 0
Charles McDermott
Independent Director6.2yrsUS$60.69k0.067%
$ 17.6k
Fred Ramsdell
Member of Scientific & Clinical Advisory Boardno datano datano data
Yu Xu
Independent Director3.8yrsUS$74.86k0%
$ 0

6.2yrs

Average Tenure

60.5yo

Average Age

Experienced Board: EQ's board of directors are considered experienced (6.2 years average tenure).